BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson AL, Grehan N. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol. 2008;216:295-306. [PMID: 18788075 DOI: 10.1002/path.2426] [Cited by in Crossref: 99] [Cited by in F6Publishing: 110] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Amalia R, Panenggak NSR, Doohan D, Rezkitha YAA, Waskito LA, Syam AF, Lubis M, Yamaoka Y, Miftahussurur M. A comprehensive evaluation of an animal model for Helicobacter pylori-associated stomach cancer: Fact and controversy. Helicobacter 2023;28:e12943. [PMID: 36627714 DOI: 10.1111/hel.12943] [Reference Citation Analysis]
2 Kole C, Charalampakis N, Sakellariou S, Papaxoinis G, Apostolou KG, Machairas N, Papanikolaou IS, Schizas D. Hereditary Diffuse Gastric Cancer: A 2022 Update. J Pers Med 2022;12. [PMID: 36556253 DOI: 10.3390/jpm12122032] [Reference Citation Analysis]
3 Yan Q, Wu Y, Li D, Li Y, Stefan-van Staden R. A-Kinase Anchoring Protein 9 Promotes Gastric Cancer Progression as a Downstream Effector of Cadherin 1. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/2830634] [Reference Citation Analysis]
4 Choi YJ, Kim B, Kim Y, Shin S, Lee K. Applying Functional Assay Evidence to Interpret Sequence Variants Identified in Hereditary Cancer Genes. Lab Med Online 2022;12:145-158. [DOI: 10.47429/lmo.2022.12.3.145] [Reference Citation Analysis]
5 Vizgan N, Jokar TO, Enayati L, Salyana M, Gotlieb VK. Presentation and treatment of aggressive, Triple‐Negative carcinosarcoma of the breast. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.6020] [Reference Citation Analysis]
6 Carneiro F. Familial and hereditary gastric cancer, an overview. Best Pract Res Clin Gastroenterol 2022;58-59:101800. [PMID: 35988963 DOI: 10.1016/j.bpg.2022.101800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Monster JL, Kemp LJS, Gloerich M, van der Post RS. Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progression. Biochim Biophys Acta Rev Cancer 2022;:188719. [PMID: 35307354 DOI: 10.1016/j.bbcan.2022.188719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vaiphei K. Morphological Aspect of Gastric Carcinomas. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_15] [Reference Citation Analysis]
9 Garcia-Pelaez J, Barbosa-Matos R, São José C, Sousa S, Gullo I, Hoogerbrugge N, Carneiro F, Oliveira C. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes. Eur J Med Genet 2022;65:104401. [PMID: 34871783 DOI: 10.1016/j.ejmg.2021.104401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Marginean EC. Gastric Cancer: Applicability and Feasibility of Molecular and Histological Classification in Clinical Practice. JMRO 2021;1:8-26. [DOI: 10.53011/jmro.2021.02.02] [Reference Citation Analysis]
11 Yao C, Li Y, Luo L, Xiong Q, Zhong X, Xie F, Feng P. Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis. PLoS One 2021;16:e0260353. [PMID: 34818353 DOI: 10.1371/journal.pone.0260353] [Reference Citation Analysis]
12 Businello G, Angerilli V, Parente P, Realdon S, Savarino E, Farinati F, Grillo F, Vanoli A, Galuppini F, Paccagnella S, Pennelli G, Mastracci L, Saragoni L, Fassan M. Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions. Int J Mol Sci 2021;22:9950. [PMID: 34576114 DOI: 10.3390/ijms22189950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Rustgi SD, Ching CK, Kastrinos F. Inherited Predisposition to Gastric Cancer. Gastrointest Endosc Clin N Am 2021;31:467-87. [PMID: 34053634 DOI: 10.1016/j.giec.2021.03.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Gullo I, Oliveira C, van der Post RS, van Dieren JM, Davis JL, Bougen-zhukov N, Guilford P, Carneiro F. Updated perspective and directions on hereditary diffuse gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00011-3] [Reference Citation Analysis]
15 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
16 Chen Y, Zhou Q, Wang H, Zhuo W, Ding Y, Lu J, Wu G, Xu N, Teng L. Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers. Cancers (Basel) 2020;12:E2236. [PMID: 32785164 DOI: 10.3390/cancers12082236] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
17 Lyons K, Le LC, Pham YT, Borron C, Park JY, Tran CTD, Tran TV, Tran HT, Vu KT, Do CD, Pelucchi C, La Vecchia C, Zgibor J, Boffetta P, Luu HN. Gastric cancer: epidemiology, biology, and prevention: a mini review. Eur J Cancer Prev. 2019;28:397-412. [PMID: 31386635 DOI: 10.1097/cej.0000000000000480] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 20.3] [Reference Citation Analysis]
18 Caggiari L, Fornasarig M, De Zorzi M, Cannizzaro R, Steffan A, De Re V. Family's History Based on the CDH1 Germline Variant (c.360delG) and a Suspected Hereditary Gastric Cancer Form. Int J Mol Sci 2020;21:E4904. [PMID: 32664545 DOI: 10.3390/ijms21144904] [Reference Citation Analysis]
19 Corso G, Montagna G, Figueiredo J, La Vecchia C, Fumagalli Romario U, Fernandes MS, Seixas S, Roviello F, Trovato C, Guerini-Rocco E, Fusco N, Pravettoni G, Petrocchi S, Rotili A, Massari G, Magnoni F, De Lorenzi F, Bottoni M, Galimberti V, Sanches JM, Calvello M, Seruca R, Bonanni B. Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review. Cancers (Basel) 2020;12:E1598. [PMID: 32560361 DOI: 10.3390/cancers12061598] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
20 Selvanathan A, Nixon CY, Zhu Y, Scietti L, Forneris F, Uribe LMM, Lidral AC, Jezewski PA, Mulliken JB, Murray JC, Buckley MF, Cox TC, Roscioli T. CDH1 Mutation Distribution and Type Suggests Genetic Differences between the Etiology of Orofacial Clefting and Gastric Cancer. Genes (Basel) 2020;11:E391. [PMID: 32260281 DOI: 10.3390/genes11040391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Renaud F, Svrcek M. [Hereditary gastric cancer: Challenges for the pathologist in 2020]. Ann Pathol 2020;40:95-104. [PMID: 32147190 DOI: 10.1016/j.annpat.2020.02.007] [Reference Citation Analysis]
22 Georgopoulos SD, Michopoulos S, Rokkas T, Apostolopoulos P, Giamarellos E, Kamberoglou D, Mentis A, Triantafyllou K. Hellenic consensus on Helicobacter pylori infection. Ann Gastroenterol 2020;33:105-24. [PMID: 32127732 DOI: 10.20524/aog.2020.0446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
23 Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
24 Mun DG, Bhin J, Kim S, Kim H, Jung JH, Jung Y, Jang YE, Park JM, Kim H, Jung Y, Lee H, Bae J, Back S, Kim SJ, Kim J, Park H, Li H, Hwang KB, Park YS, Yook JH, Kim BS, Kwon SY, Ryu SW, Park DY, Jeon TY, Kim DH, Lee JH, Han SU, Song KS, Park D, Park JW, Rodriguez H, Kim J, Lee H, Kim KP, Yang EG, Kim HK, Paek E, Lee S, Lee SW, Hwang D. Proteogenomic Characterization of Human Early-Onset Gastric Cancer. Cancer Cell 2019;35:111-124.e10. [PMID: 30645970 DOI: 10.1016/j.ccell.2018.12.003] [Cited by in Crossref: 109] [Cited by in F6Publishing: 120] [Article Influence: 27.3] [Reference Citation Analysis]
25 Kim N. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism. J Gastroenterol Hepatol 2019;34:1287-95. [PMID: 30828872 DOI: 10.1111/jgh.14646] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
26 Aiello NM, Kang Y. Context-dependent EMT programs in cancer metastasis. J Exp Med. 2019;216:1016-1026. [PMID: 30975895 DOI: 10.1084/jem.20181827] [Cited by in Crossref: 247] [Cited by in F6Publishing: 264] [Article Influence: 61.8] [Reference Citation Analysis]
27 Figueiredo J, Melo S, Carneiro P, Moreira AM, Fernandes MS, Ribeiro AS, Guilford P, Paredes J, Seruca R. Clinical spectrum and pleiotropic nature of CDH1 germline mutations. J Med Genet. 2019;56:199-208. [PMID: 30661051 DOI: 10.1136/jmedgenet-2018-105807] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
28 Rotondo R, Rizzolio F, Perin T, Berretta M, Zanconati F, Giordano A, Canzonieri V. Pathological Diagnosis and Classification of Gastric Epithelial Tumours. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018;9:1421. [PMID: 30568591 DOI: 10.3389/fphar.2018.01421] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
30 Medrado BF, da Costa Martins B. The Role of Endoscopy. In: de Castria TB, Guindalini RSC, editors. Diffuse Gastric Cancer. Cham: Springer International Publishing; 2018. pp. 15-25. [DOI: 10.1007/978-3-319-95234-5_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Moslim MA, Heald B, Tu C, Burke CA, Walsh RM. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer. Surgery. 2018;164:754-759. [PMID: 30145018 DOI: 10.1016/j.surg.2018.05.059] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
32 Abbas M, Faggian A, Sintali DN, Khan GJ, Naeem S, Shi M, Dingding C. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 2018;103:1688-700. [DOI: 10.1016/j.biopha.2018.04.178] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
33 van der Post RS, Carneiro F. Emerging Concepts in Gastric Neoplasia: Heritable Gastric Cancers and Polyposis Disorders. Surg Pathol Clin. 2017;10:931-945. [PMID: 29103540 DOI: 10.1016/j.path.2017.07.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
34 Spoto CP, Gullo I, Carneiro F, Montgomery EA, Brosens LA. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing. Seminars in Diagnostic Pathology 2018;35:170-83. [DOI: 10.1053/j.semdp.2018.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
35 Zylberberg HM, Sultan K, Rubin S. Hereditary diffuse gastric cancer: One family’s story. World J Clin Cases 2018; 6(1): 1-5 [PMID: 29376063 DOI: 10.12998/wjcc.v6.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
36 Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Calogero A, Dodaro CA, Santangelo M. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Res Int. 2017;2017:7869802. [PMID: 29094049 DOI: 10.1155/2017/7869802] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 9.2] [Reference Citation Analysis]
37 Tabatabaiefar MA, Moridnia A. Gastrointestinal Cancers. In: Mehdipour P, editor. Cancer Genetics and Psychotherapy. Cham: Springer International Publishing; 2017. pp. 589-625. [DOI: 10.1007/978-3-319-64550-6_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
38 Langner C. Hereditäres Magen- und Pankreaskarzinom. Pathologe 2017;38:164-9. [DOI: 10.1007/s00292-017-0297-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Boland CR, Yurgelun MB. Historical Perspective on Familial Gastric Cancer. Cell Mol Gastroenterol Hepatol 2017;3:192-200. [PMID: 28275686 DOI: 10.1016/j.jcmgh.2016.12.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
40 Cheng S, Cui D. Screening and Identification of Biomarkers from Gastric Cancer Saliva Metabolites. Translational Medicine Research 2017. [DOI: 10.1007/978-94-024-0951-2_4] [Reference Citation Analysis]
41 Pérez Cala T, Universidad de Antioquia. Factores genéticos y epigenéticos del cáncer gástrico. Actual Biol 2017;39:5-20. [DOI: 10.17533/udea.acbi.v39n106a01] [Reference Citation Analysis]
42 Shangli C, Cui D. Metabolic Profiles and High-Accuracy Diagnosis Model Based on Plasma Metabolomics of Gastric Cancer Patients. Translational Medicine Research 2017. [DOI: 10.1007/978-94-024-0951-2_5] [Reference Citation Analysis]
43 Oh S, Kim N, Kwon JW, Shin CM, Choi YJ, Lee DH, Jung HC. Effect of Helicobacter pylori Eradication and ABO Genotype on Gastric Cancer Development. Helicobacter 2016;21:596-605. [PMID: 27191536 DOI: 10.1111/hel.12317] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
44 Zhang C, Min L, Liu J, Tian W, Han Y, Qu L, Shou C. Integrated analysis identified an intestinal-like and a diffuse-like gene sets that predict gastric cancer outcome. Tumour Biol 2016. [PMID: 27858295 DOI: 10.1007/s13277-016-5454-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
45 Pantelis D, Hüneburg R, Adam R, Holzapfel S, Gevensleben H, Nattermann J, Strassburg CP, Aretz S, Kalff JC. Prophylactic total gastrectomy in the management of hereditary tumor syndromes. Int J Colorectal Dis 2016;31:1825-33. [PMID: 27682646 DOI: 10.1007/s00384-016-2656-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
46 Jia Y, Cao B, Yang Y, Linghu E, Zhan Q, Lu Y, Yu Y, Herman JG, Guo M. Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer. Oncotarget 2015;6:33470-85. [PMID: 26396173 DOI: 10.18632/oncotarget.5272] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
47 Alkebsi L, Handa H, Yokohama A, Saitoh T, Tsukamoto N, Murakami H. Chromosome 16q genes CDH1, CDH13 and ADAMTS18 are correlated and frequently methylated in human lymphoma. Oncol Lett 2016;12:3523-30. [PMID: 27900031 DOI: 10.3892/ol.2016.5116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
48 Marqués-Lespier JM, González-Pons M, Cruz-Correa M. Current Perspectives on Gastric Cancer. Gastroenterol Clin North Am 2016;45:413-28. [PMID: 27546840 DOI: 10.1016/j.gtc.2016.04.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 11.6] [Reference Citation Analysis]
49 Baniak N, Senger JL, Ahmed S, Kanthan SC, Kanthan R. Gastric biomarkers: a global review. World J Surg Oncol. 2016;14:212. [PMID: 27514667 DOI: 10.1186/s12957-016-0969-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 9.6] [Reference Citation Analysis]
50 Poh AR, O'Donoghue RJ, Ernst M, Putoczki TL. Mouse models for gastric cancer: Matching models to biological questions. J Gastroenterol Hepatol 2016;31:1257-72. [PMID: 26809278 DOI: 10.1111/jgh.13297] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
51 Monahan KJ, Hopkins L. Diagnosis and Management of Hereditary Gastric Cancer. In: Pichert G, Jacobs C, editors. Rare Hereditary Cancers. Cham: Springer International Publishing; 2016. pp. 45-60. [DOI: 10.1007/978-3-319-29998-3_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
52 Skierucha M, Milne AN, Offerhaus GJA, Polkowski WP, Maciejewski R, Sitarz R. Molecular alterations in gastric cancer with special reference to the early-onset subtype. World J Gastroenterol 2016; 22(8): 2460-2474 [PMID: 26937134 DOI: 10.3748/wjg.v22.i8.2460] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
53 Li Y, Ran R, Guan Y, Zhu X, Kang S. Aberrant Methylation of the E-Cadherin Gene Promoter Region in the Endometrium of Women With Uterine Fibroids. Reprod Sci 2016;23:1096-102. [DOI: 10.1177/1933719116630415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
54 van der Post RS, Gullo I, Oliveira C, Tang LH, Grabsch HI, O'Donovan M, Fitzgerald RC, van Krieken H, Carneiro F. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future. Adv Exp Med Biol 2016;908:371-91. [PMID: 27573781 DOI: 10.1007/978-3-319-41388-4_18] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
55 Jomrich G, Schoppmann SF. Targeting HER 2 and angiogenesis in gastric cancer. Expert Rev Anticancer Ther 2016;16:111-22. [PMID: 26567753 DOI: 10.1586/14737140.2016.1121110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
56 Tan RYC, Ngeow J. Hereditary diffuse gastric cancer: What the clinician should know. World J Gastrointest Oncol 2015; 7(9): 153-160 [PMID: 26380059 DOI: 10.4251/wjgo.v7.i9.153] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
57 Colvin H, Yamamoto K, Wada N, Mori M. Hereditary Gastric Cancer Syndromes. Surg Oncol Clin N Am 2015;24:765-77. [PMID: 26363540 DOI: 10.1016/j.soc.2015.06.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
58 Gurzu S, Jung I, Orlowska J, Sugimura H, Kadar Z, Turdean S, Bara T. Hereditary diffuse gastric cancer--An overview. Pathol Res Pract. 2015;211:629-632. [PMID: 26150395 DOI: 10.1016/j.prp.2015.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
59 van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361-374. [PMID: 25979631 DOI: 10.1136/jmedgenet-2015-103094] [Cited by in Crossref: 365] [Cited by in F6Publishing: 387] [Article Influence: 45.6] [Reference Citation Analysis]
60 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol. 2015;16:e60-e70. [PMID: 25638682 DOI: 10.1016/s1470-2045(14)71016-2] [Cited by in Crossref: 219] [Cited by in F6Publishing: 173] [Article Influence: 27.4] [Reference Citation Analysis]
61 Zhao Y, Feng F, Zhou YN. Stem cells in gastric cancer. World J Gastroenterol 2015; 21(1): 112-123 [PMID: 25574084 DOI: 10.3748/wjg.v21.i1.112] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
62 Pattison S, Boussioutas A. Pathophysiology of Hereditary Diffuse Gastric Cancer. Gastric Cancer 2015. [DOI: 10.1007/978-3-319-15826-6_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Yi JH, Do IG, Jang J, Kim ST, Kim KM, Park SH, Park JO, Park YS, Lim HY, Kang WK. Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancer. Sci Rep. 2014;4:7592. [PMID: 25534230 DOI: 10.1038/srep07592] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
64 Carcas LP. Gastric cancer review. J Carcinog. 2014;13:14. [PMID: 25589897 DOI: 10.4103/1477-3163.146506] [Cited by in Crossref: 136] [Cited by in F6Publishing: 157] [Article Influence: 15.1] [Reference Citation Analysis]
65 Pinheiro H, Oliveira C, Seruca R, Carneiro F. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Best Pract Res Clin Gastroenterol 2014;28:1055-68. [PMID: 25439071 DOI: 10.1016/j.bpg.2014.09.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
66 Moreira-Nunes CA, Barros MBL, do Nascimento Borges B, Montenegro RC, Lamarão LM, Ribeiro HF, Bona AB, Assumpção PP, Rey JA, Pinto GR, Burbano RR. Genetic screening analysis of patients with hereditary diffuse gastric cancer from northern and northeastern Brazil. Hered Cancer Clin Pract 2014;12:18. [PMID: 25180051 DOI: 10.1186/1897-4287-12-18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
67 Liu X, Chu KM. E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res Int. 2014;2014:637308. [PMID: 25184143 DOI: 10.1155/2014/637308] [Cited by in Crossref: 63] [Cited by in F6Publishing: 83] [Article Influence: 7.0] [Reference Citation Analysis]
68 Park JY, Forman D, Greenberg ER, Herrero R. Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed? Curr Oncol Rep. 2013;15:517-525. [PMID: 24101366 DOI: 10.1007/s11912-013-0341-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
69 Petridis C, Shinomiya I, Kohut K, Gorman P, Caneppele M, Shah V, Troy M, Pinder SE, Hanby A, Tomlinson I, Trembath RC, Roylance R, Simpson MA, Sawyer EJ. Germline CDH1 mutations in bilateral lobular carcinoma in situ. Br J Cancer. 2014;110:1053-1057. [PMID: 24366306 DOI: 10.1038/bjc.2013.792] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
70 Pinho SS, Carvalho S, Marcos-pinto R, Magalhães A, Oliveira C, Gu J, Dinis-ribeiro M, Carneiro F, Seruca R, Reis CA. Gastric cancer: adding glycosylation to the equation. Trends in Molecular Medicine 2013;19:664-76. [DOI: 10.1016/j.molmed.2013.07.003] [Cited by in Crossref: 75] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
71 Carneiro P, Figueiredo J, Bordeira-Carriço R, Fernandes MS, Carvalho J, Oliveira C, Seruca R. Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opin Ther Targets 2013;17:1187-201. [PMID: 23957294 DOI: 10.1517/14728222.2013.827174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
72 Uppal DS, Powell SM. Genetics/genomics/proteomics of gastric adenocarcinoma. Gastroenterol Clin North Am 2013;42:241-60. [PMID: 23639639 DOI: 10.1016/j.gtc.2013.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
73 Rugge M, Capelle LG, Cappellesso R, Nitti D, Kuipers EJ. Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol 2013;27:205-23. [PMID: 23809241 DOI: 10.1016/j.bpg.2012.12.007] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 7.9] [Reference Citation Analysis]
74 Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Söderberg O, Seruca R, Santos MA, Schmitt F, Paredes J. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. J Pathol 2013;229:705-18. [PMID: 23180380 DOI: 10.1002/path.4143] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
75 Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013;31:868-875. [PMID: 23341533 DOI: 10.1200/jco.2012.44.4612] [Cited by in Crossref: 123] [Cited by in F6Publishing: 134] [Article Influence: 12.3] [Reference Citation Analysis]
76 Guilford P, Humar B. Molecular Mechanisms of Hereditary Diffuse Gastric Cancer Initiation and Progression. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_6] [Reference Citation Analysis]
77 Ferrara F, Corso G, Roviello F. Prophylactic Total Gastrectomy in CDH1 Germline Mutation Carriers. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_14] [Reference Citation Analysis]
78 Carneiro F, Oliveira C, Seruca R. Hereditary Diffuse Gastric Cancer and Other Gastric Cancers Associated with Hereditary Predisposition Syndromes. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_6] [Reference Citation Analysis]
79 Carneiro F. Pathology of Hereditary Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
80 De Falco G, Videtta AD. Clinical Criteria for Familial Gastric Cancer Definition. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_13] [Reference Citation Analysis]
81 Carneiro F, Lauwers GY. Epithelial Tumours of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
82 Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3:251-261. [PMID: 22943016 DOI: 10.3978/j.issn.2078-6891.2012.021] [Cited by in F6Publishing: 206] [Reference Citation Analysis]
83 Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Sim窄es-Correia J, Oliveira MJ. Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta. 2012;1826:297-311. [PMID: 22613680 DOI: 10.1016/j.bbcan.2012.05.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 101] [Article Influence: 4.0] [Reference Citation Analysis]
84 Yu QM, Wang XB, Luo J, Wang S, Fang XH, Yu JL, Ling ZQ. CDH1 methylation in preoperative peritoneal washes is an independent prognostic factor for gastric cancer. J Surg Oncol. 2012;106:765-771. [PMID: 22514028 DOI: 10.1002/jso.23116] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
85 Blair VR. Familial gastric cancer: genetics, diagnosis, and management. Surg Oncol Clin N Am 2012;21:35-56. [PMID: 22098830 DOI: 10.1016/j.soc.2011.09.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
86 Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer. 2012;12:8. [PMID: 22225527 DOI: 10.1186/1471-2407-12-8] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
87 Kluijt I, Siemerink EJ, Ausems MG, van Os TA, de Jong D, Simões-Correia J, van Krieken JH, Ligtenberg MJ, Figueiredo J, van Riel E, Sijmons RH, Plukker JT, van Hillegersberg R, Dekker E, Oliveira C, Cats A, Hoogerbrugge N; Dutch Working Group on Hereditary Gastric Cancer. CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling. Int J Cancer 2012;131:367-76. [PMID: 22020549 DOI: 10.1002/ijc.26398] [Cited by in Crossref: 85] [Cited by in F6Publishing: 91] [Article Influence: 7.1] [Reference Citation Analysis]
88 Ottenhof NA, de Wilde RF, Morsink FH, de Leng WW, Ausems MG, Morreau H, van Hillegersberg R, Offerhaus GJ, Milne AN. Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report. Hum Pathol 2012;43:457-61. [PMID: 21992816 DOI: 10.1016/j.humpath.2011.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
89 Svrcek M. [Case n(o) 6: Signet ring cell intramucosal carcinoma in hereditary diffuse gastric cancer with mutated CDH1 gene]. Ann Pathol 2011;31:381-4. [PMID: 21982246 DOI: 10.1016/j.annpat.2011.07.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
90 Wilcox R, Perpich M, Noffsinger A, Posner MC, Cooper K. Hereditary diffuse gastric cancer: multidisciplinary case report with review of the literature. Patholog Res Int 2011;2011:845821. [PMID: 21331337 DOI: 10.4061/2011/845821] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
91 Svrcek M. [Hereditary gastric cancer: the pathologist's point of view]. Ann Pathol 2010;30:84-7. [PMID: 21055555 DOI: 10.1016/j.annpat.2010.08.005] [Reference Citation Analysis]
92 Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C;  International Gastric Cancer Linkage Consortium. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47:436-444. [PMID: 20591882 DOI: 10.1136/jmg.2009.074237] [Cited by in Crossref: 380] [Cited by in F6Publishing: 411] [Article Influence: 29.2] [Reference Citation Analysis]
93 Jatoi I, Benson JR, Liau SS, Chen Y, Cisco RM, Norton JA, Moley JF, Khalifeh KW, Choti MA. The role of surgery in cancer prevention. Curr Probl Surg 2010;47:750-830. [PMID: 20816140 DOI: 10.1067/j.cpsurg.2010.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
94 Wolf E, Geigl J, Svrcek M, Vieth M, Langner C. Hereditäres Magenkarzinom. Pathologe 2010;31:423-9. [DOI: 10.1007/s00292-010-1353-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
95 Carneiro F, Oliveira C, Seruca R. Pathology and genetics of familial gastric cancer. Int J Surg Pathol. 2010;18:33S-36S. [PMID: 20484258 DOI: 10.1177/1066896910366463] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
96 Matsukuma KE, Mullins FM, Dietz L, Zehnder JL, Ford JM, Chun NM, Schrijver I. Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation. Human Pathology 2010;41:1200-3. [DOI: 10.1016/j.humpath.2010.01.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
97 Song EY, Shurin MR, Tourkova IL, Gutkin DW, Shurin GV. Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells. Cancer Res 2010;70:4394-401. [PMID: 20460540 DOI: 10.1158/0008-5472.CAN-10-0427] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
98 Guilford P, Humar B, Blair V. Hereditary diffuse gastric cancer: Translation of CDH1 germline mutations into clinical practice. Gastric Cancer. 2010;13:1-10. [PMID: 20373070 DOI: 10.1007/s10120-009-0531-x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 114] [Article Influence: 8.5] [Reference Citation Analysis]
99 Sakamoto LHT, De Camargo B, Cajaiba M, Soares FA, Vettore AL. MT1G Hypermethylation: A Potential Prognostic Marker for Hepatoblastoma. Pediatr Res 2010;67:387-93. [DOI: 10.1203/pdr.0b013e3181d01863] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
100 Lao-Sirieix P, Caldas C, Fitzgerald RC. Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev 2010;20:210-7. [PMID: 20347291 DOI: 10.1016/j.gde.2010.03.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
101 Schrader K, Huntsman D. Hereditary diffuse gastric cancer. Cancer Treat Res 2010;155:33-63. [PMID: 20517687 DOI: 10.1007/978-1-4419-6033-7_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
102 Pinheiro H, Bordeira-Carriço R, Seixas S, Carvalho J, Senz J, Oliveira P, Inácio P, Gusmão L, Rocha J, Huntsman D, Seruca R, Oliveira C. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 2010;19:943-52. [PMID: 19965908 DOI: 10.1093/hmg/ddp537] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
103 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/x00439-009-0722-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
104 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/s00439-009-0722-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 145] [Article Influence: 11.1] [Reference Citation Analysis]
105 Uhm KO, Lee JO, Lee YM, Lee ES, Kim HS, Park SH. Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma. J Cancer Res Clin Oncol. 2010;136:187-194. [PMID: 19655168 DOI: 10.1007/s00432-009-0646-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
106 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)60617-6] [Cited by in Crossref: 675] [Cited by in F6Publishing: 758] [Article Influence: 48.2] [Reference Citation Analysis]
107 Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477-490. [PMID: 19625077 DOI: 10.1016/s0140-6736(09)] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
108 Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carriço R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D, Seruca R. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009;136:2137-48. [PMID: 19269290 DOI: 10.1053/j.gastro.2009.02.065] [Cited by in Crossref: 120] [Cited by in F6Publishing: 128] [Article Influence: 8.6] [Reference Citation Analysis]
109 Humar B, Guilford P. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci. 2009;100:1151-1157. [PMID: 19432899 DOI: 10.1111/j.1349-7006.2009.01163.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 4.7] [Reference Citation Analysis]
110 Oliveira C, Seruca R, Carneiro F. Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 2009;23:147-57. [PMID: 19414142 DOI: 10.1016/j.bpg.2009.02.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
111 Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A, Corso G, Schouten J, Fitzgerald R, Vogelsang H. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet. 2009;18:1545-1555. [PMID: 19168852 DOI: 10.1093/hmg/ddp046] [Cited by in Crossref: 146] [Cited by in F6Publishing: 157] [Article Influence: 10.4] [Reference Citation Analysis]